#SupplementaryEarningsExplanation

For Q3 FY2026, net sales were 88.1 billion yen (2.0% YoY increase), operating income was 6.5 billion yen (21.3% YoY increase), and quarterly net income attributable to owners of parent was 6.1 billion yen (113.9% YoY increase), reflecting growth in both revenue and profit.

For the cumulative third quarter of FY2026, net sales were JPY 498.25 billion, a 0.2% increase year-over-year. Operating income was JPY 4.932 billion, down 5.5% year-over-year, and net income attributable to owners of parent was JPY 3.876 billion, down 2.4% year-over-year.

For the fiscal year ending December 2025, consolidated net sales reached 260.25 billion yen (18.1% YoY increase), consolidated operating income was 3.919 billion yen (78.4% YoY increase), and net income attributable to owners of parent was 3.123 billion yen (137.9% YoY increase), achieving the highest profits since listing.

For Q1 FY2026, net sales were JPY 10,645 million (YoY +1.7%), operating income was JPY 1,518 million (YoY -0.7%), driven by strong growth of +43.1% YoY in the healthcare business's Slimore Coffee.

For the third quarter of the fiscal year ending March 2026, net sales totaled 131.3 billion yen (YoY 101.5%), operating income was 7.1 billion yen (YoY 94.6%), and net income attributable to owners of parent was 3.7 billion yen (YoY 81.6%).

For the cumulative third quarter of the fiscal year ending March 2026, net sales were 81.82 billion yen (YoY +9.0%), operating income was 3.143 billion yen (YoY +44.8%), and net income attributable to owners of parent for the quarter was 2.484 billion yen (YoY +49.9%).